Nothing Special   »   [go: up one dir, main page]

Roses et al., 2014 - Google Patents

New applications of disease genetics and pharmacogenetics to drug development

Roses et al., 2014

View HTML
Document ID
10434931552332094692
Author
Roses A
Saunders A
Lutz M
Zhang N
Hariri A
Asin K
Crenshaw D
Budur K
Burns D
Brannan S
Publication year
Publication venue
Current opinion in pharmacology

External Links

Snippet

Highlights•A variable polyT variation within TOMM40 was associated with MCI-AD.•TOMM40 genotypes are 97% informative for estimating age of onset risk.•TOMMORROW is a Phase III delay of onset of MCI-AD in 65–83 year olds.•Pioglitazone has a large safety experience …
Continue reading at www.sciencedirect.com (HTML) (other versions)

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Hybridisation probes
    • C12Q1/6883Hybridisation probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6827Hybridisation assays for mutation or polymorphism detection
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06FELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
    • G06F19/18Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for functional genomics or proteomics, e.g. genotype-phenotype associations, linkage disequilibrium, population genetics, binding site identification, mutagenesis, genotyping or genome annotation, protein-protein interactions or protein-nucleic acid interactions

Similar Documents

Publication Publication Date Title
Roses et al. New applications of disease genetics and pharmacogenetics to drug development
Corbett et al. Intronic ATTTC repeat expansions in STARD7 in familial adult myoclonic epilepsy linked to chromosome 2
Reitz et al. Genetic variants in the Fat and Obesity Associated (FTO) gene and risk of Alzheimer's disease
Bonder et al. Genetic and epigenetic regulation of gene expression in fetal and adult human livers
Saykin et al. Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plans
Hamza et al. Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease
Debette et al. Genome-wide studies of verbal declarative memory in nondemented older people: the Cohorts for Heart and Aging Research in Genomic Epidemiology consortium
Yan et al. Frameshift and novel mutations in FUS in familial amyotrophic lateral sclerosis and ALS/dementia
Laje et al. Genetic markers of suicidal ideation emerging during citalopram treatment of major depression
International Headache Genetics Consortium Anttila Verneri verneri. anttila@ sanger. ac. uk 1 2 b Stefansson Hreinn 3 Kallela Mikko 4 Todt Unda 5 6 Terwindt Gisela M 7 Calafato M Stella 1 8 Nyholt Dale R 9 Dimas Antigone S 1 10 11 Freilinger Tobias 12 13 Müller-Myhsok Bertram 14 Artto Ville 4 Inouye Michael 1 15 Alakurtti Kirsi 1 2 Kaunisto Mari A 2 16 Hämäläinen Eija 1 2 de Vries Boukje 15 Stam Anine H 7 Weller Claudia M 15 Heinze Axel 17 Heinze-Kuhn Katja 17 Goebel Ingrid 5 6 Borck Guntram 5 6 Göbel Hartmut 17 Steinberg Stacy 3 Wolf Christiane 14 Björnsson Asgeir 3 Gudmundsson Gretar 18 Kirchmann Malene 19 Hauge Anne 19 Werge Thomas 20 Schoenen Jean 21 Eriksson Johan G 16 22 23 24 Hagen Knut 25 Stovner Lars 25 Wichmann H-Erich 26 27 28 Meitinger Thomas 29 30 Alexander Michael 31 32 Moebus Susanne 33 Schreiber Stefan 34 35 Aulchenko Yurii S 36 Breteler Monique MB 36 Uitterlinden Andre G 37 Hofman Albert 36 van Duijn Cornelia M 36 Tikka-Kleemola Päivi 38 Vepsäläinen Salli 4 Lucae Susanne 14 Tozzi Federica 39 Muglia Pierandrea 39 40 Barrett Jeffrey 1 Kaprio Jaakko 2 24 41 Färkkilä Markus 4 Peltonen Leena 1 2 42 Stefansson Kari 3 Zwart John-Anker 25 43 Ferrari Michel D 7 Olesen Jes 19 Daly Mark 42 Wessman Maija 2 16 van den Maagdenberg Arn MJM 7 15 Dichgans Martin 12 13 Kubisch Christian 5 6 44 45 Dermitzakis Emmanouil T 11 Frants Rune R 15 Palotie Aarno aarno. palotie@ sanger. ac. uk 1 2 42 46 47 bw Genome-wide association study of migraine implicates a common susceptibility variant on 8q22. 1
Illig et al. A genome-wide perspective of genetic variation in human metabolism
Li et al. Genome-wide association studies of antidepressant class response and treatment-resistant depression
Tan et al. Analysis of GWAS-linked loci in Parkinson disease reaffirms PARK16 as a susceptibility locus
Mangone et al. Early cognitive decline after bilateral subthalamic deep brain stimulation in Parkinson's disease patients with GBA mutations
Murphy Jr et al. BDNF and CREB1 genetic variants interact to affect antidepressant treatment outcomes in geriatric depression
Marshe et al. Genome-wide analysis suggests the importance of vascular processes and neuroinflammation in late-life antidepressant response
Lin et al. Cross-tissue exploration of genetic and epigenetic effects on brain gray matter in schizophrenia
Ohi et al. The SIGMAR1 gene is associated with a risk of schizophrenia and activation of the prefrontal cortex
Tammiste et al. Whole-exome sequencing identifies a polymorphism in the BMP5 gene associated with SSRI treatment response in major depression
Firouzabadi et al. Genetic variants of angiotensin-converting enzyme are linked to autism: a case-control study
Julià et al. Association of the PDE3A-SLCO1C1 locus with the response to anti-TNF agents in psoriasis
Engelmann et al. Epigenetic signatures in antidepressant treatment response: a methylome-wide association study in the EMC trial
Liu et al. Influence of the rs1080985 single nucleotide polymorphism of the CYP2D6 gene and APOE polymorphism on the response to donepezil treatment in patients with Alzheimer's disease in China
Grossman et al. Alzheimer’s disease: diagnostics, prognostics and the road to prevention
Mahmoudi et al. The MIR137 VNTR rs58335419 is associated with cognitive impairment in schizophrenia and altered cortical morphology